Загрузка...
Personalized peptide vaccination for cervical cancer patients who have received prior platinum-based chemotherapy
A feasibility study was performed to evaluate the immunological efficacy and safety of a personalized peptide vaccine (PPV) for cervical cancer patients who have received platinum-based chemotherapy. A total of 24 patients with standard chemotherapy-resistant cervical cancer, including 18 recurrent...
Сохранить в:
| Опубликовано в: : | Cancer Sci |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley & Sons, Ltd
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4582979/ https://ncbi.nlm.nih.gov/pubmed/26122553 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12729 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|